Biotest Aktiengesellschaft reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was EUR 137.2 million compared to EUR 137.8 million a year ago. Net loss was EUR 15 million compared to EUR 4.1 million a year ago. Basic loss per share from continuing operations was EUR 0.39 compared to EUR 0.11 a year ago.
For the six months, sales was EUR 253.1 million compared to EUR 257.8 million a year ago. Net loss was EUR 19.9 million compared to EUR 18.2 million a year ago. Basic loss per share from continuing operations was EUR 0.5 compared to EUR 0.47 a year ago.